Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer
Clinical trial NCT06868758 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06868758
- Sponsor
- Chongqing General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-01
- Primary completion
- 2025-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.